Contemporary trends in cardiac electrophysiology procedures in the United States, and impact of a global pandemic
暂无分享,去创建一个
T. Bunch | B. Steinberg | Emily P. Zeitler | T. Baykaner | Wendy S. Tzou | Monte Scott | J. Piccini | Andrea M. Russo
[1] A. Verma,et al. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. , 2022, The New England journal of medicine.
[2] T. Bunch,et al. Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter defibrillator: An updated systematic review and meta-analysis of randomized control trials. , 2022, Heart rhythm.
[3] B. Nazer,et al. Temporal and geographical trends in women operators of electrophysiology procedures in the United States. , 2022, Heart rhythm.
[4] P. Santangeli,et al. Electrophysiology and Interventional Cardiology Procedure Volumes During the Coronavirus Disease 2019 Pandemic , 2021, Cardiac Electrophysiology Clinics.
[5] C. Morillo,et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. , 2020, The New England journal of medicine.
[6] R. Jackson,et al. Ten‐year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS‐QI 51) , 2020, Internal medicine journal.
[7] G. Breithardt,et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.
[8] Z. Kalarus,et al. Temporal trends in availability and efficacy of catheter ablation for atrial fibrillation and atrial flutter in a highly populated urban area. , 2020, Kardiologia polska.
[9] I. Ranasinghe,et al. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates. , 2019, Circulation. Cardiovascular quality and outcomes.
[10] Seil Oh,et al. Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study , 2019, Korean circulation journal.
[11] K. Anstrom,et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.
[12] B. Gersh,et al. Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trials. , 2017, Heart rhythm.
[13] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[14] John L Sapp,et al. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.
[15] Dhanunjaya R. Lakkireddy,et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. , 2015, Heart rhythm.
[16] J. Hartikainen,et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. , 2012, The New England journal of medicine.
[17] Stephan Willems,et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial , 2010, The Lancet.
[18] Margaret C Fang,et al. Trends in catheter ablation for atrial fibrillation in the United States. , 2009, Journal of hospital medicine.
[19] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[20] J. Camm,et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. , 2000, Journal of the American College of Cardiology.